SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-21-008294
Filing Date
2021-01-28
Accepted
2021-01-27 19:22:00
Documents
2
Period of Report
2020-12-07
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm214421d1_8ka.htm 8-K/A 19708
2 EXHIBIT 10.1 tm214421d1_ex10-1.htm EX-10.1 453570
  Complete submission text file 0001104659-21-008294.txt   474649
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-33958 | Film No.: 21561448
SIC: 2834 Pharmaceutical Preparations